EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that its presentation at the Kaufman Bros. 14th Annual Investor Conference to be held on September 7-8, 2011, at the W Hotel New York has been rescheduled to a different time.
